Directorio

We are doing this study to find out if an experimental drug called CABA-201 (the study drug) is a safe and effective option for people with systemic sclerosis.

People in this study will be placed into one of two groups by chance, like flipping a coin. One group will get two medicines called DSP107 and Atezolizumab together. The other group will get a medicine called Fruquintinib by itself. Each treatment cycle lasts 4 weeks and can continue for up to 2 years. Doctors will check health and safety during the study. After the last dose, there will be a follow-up period of up to 90 days.

We are doing this study to find out how well an experimental drug called DSP-5336 (the study drug) works in people with AML or ALL.

We have created this repository as a way for people to let us know they are interested in being contacted about future research studies. These studies will aim to improve the health and wellbeing of people by using mobile technology or other interventions. If you would like more information please contact us at dbhtl@duke.edu

Our Duke Vaccine and Trials Unit Volunteer Registry is a way for people to let our team know that you are interested in learning more about any of our vaccine studies. For more information or to sign up, visit us at: https://redcap.duke.edu/redcap/surveys/?s=WPL7XPK4JYHY4NYK

Our Duke Health and Exercise Research Trials Registry is a way for people to let our team know that they are interested in learning more about any of our studies for which they may qualify. Our studies include both healthy people and those who may have certain medical conditions.